TARA - Protara Therapeutics, Inc.

QQQ $ 612.11 $ 7.61 (1.26 %)

DIA $ 467.12 $ 5.24 (1.13 %)

SPY $ 671.75 $ 6.91 (1.04 %)

TLT $ 91.68 $ 0.35 (0.38 %)

GLD $ 401.36 $ 14.16 (3.64 %)

Previous Close

$ 5.56

Open

$ 5.70

Bid

$ 5.36 x 175

Ask

$ 5.87 x 5

Day's Range

$ 5.46 - $ 5.76

52 Week Range

$ 1.78 - $ 10.48

Volume

319,229

Average Volume

Market Cap

235.03M

Beta (5Y Monthly)

$ 1.56

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-11-2025	06-30-2025	10-Q
2	05-08-2025	03-31-2025	10-Q
3	03-05-2025	01-01-1970	10-K
4	11-12-2024	09-30-2024	10-Q
5	08-06-2024	06-30-2024	10-Q
6	05-02-2024	03-31-2024	10-Q
7	03-13-2024	12-31-2023	10-K
8	11-03-2023	09-30-2023	10-Q
9	08-03-2023	06-30-2023	10-Q
10	05-04-2023	03-31-2023	10-Q
11	03-08-2023	12-31-2022	10-K
12	11-03-2022	09-30-2022	10-Q
13	08-09-2022	06-30-2022	10-Q
14	05-05-2022	03-31-2022	10-Q
15	03-09-2022	12-31-2021	10-K
16	11-04-2021	09-30-2021	10-Q
17	08-05-2021	06-30-2021	10-Q
18	05-06-2021	03-31-2021	10-Q
19	03-11-2021	12-31-2020	10-K
20	11-12-2020	09-30-2020	10-Q
21	07-31-2020	06-30-2020	10-Q
22	05-13-2020	03-31-2020	10-Q
23	03-20-2020	12-31-2019	10-K
24	10-31-2019	09-30-2019	10-Q
25	08-07-2019	06-30-2019	10-Q
26	05-08-2019	03-31-2019	10-Q
27	03-13-2019	12-31-2018	10-K
28	11-07-2018	09-30-2018	10-Q
29	08-07-2018	06-30-2018	10-Q
30	05-09-2018	03-31-2018	10-Q
31	03-14-2018	12-31-2017	10-K
32	11-07-2017	09-30-2017	10-Q
33	08-07-2017	06-30-2017	10-Q
34	05-10-2017	03-31-2017	10-Q
35	03-16-2017	12-31-2016	10-K
36	11-07-2016	09-30-2016	10-Q
37	08-08-2016	06-30-2016	10-Q
38	05-09-2016	03-31-2016	10-Q
39	03-14-2016	12-31-2015	10-K
40	11-12-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12 Health Care Stocks Moving In Monday's P...
09/22/2025 12:09:30

12 Health Care Stocks Moving In Thursday's...
08/28/2025 21:06:27

Protara Therapeutics Q2 EPS $(0.35) Beats ...
08/11/2025 12:15:20

Protara Therapeutics (NASDAQ:TARA) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of ...

Protara Therapeutics Announces Addition To...
06/30/2025 12:10:08

Jones Trading Initiates Coverage On Protar...
05/22/2025 15:04:45

Jones Trading analyst Soumit Roy initiates coverage on Protara Therapeutics (NASDAQ:TARA) with a Buy rating and announces Pr...

Protara Therapeutics Q1 EPS $(0.29) Beats ...
05/08/2025 12:08:01

Protara Therapeutics (NASDAQ:TARA) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of ...

12 Health Care Stocks Moving In Monday's I...
04/28/2025 17:05:53

crude-oil-down-2-roper-technologies-increases-2025-outlook

Crude Oil Down 2%; Roper Technologies Incr...
04/28/2025 16:38:56

dow-jumps-over-150-points-dominos-pizza-posts-upbeat-earnings

Dow Jumps Over 150 Points; Domino's Pizza ...
04/28/2025 13:56:16

HC Wainwright & Co. Reiterates Buy on Prot...
04/28/2025 11:50:38

HC Wainwright & Co. analyst Andres Maldonado reiterates Protara Therapeutics (NASDAQ:TARA) with a Buy and maintains $23 ...

Reported Saturday, Protara Therapeutics Sh...
04/28/2025 07:19:47

TARA-002 demonstrates 100% complete response rate at any time and 67% 12-month landmark complete response rate in BCG-Unrespons...

Protara Therapeutics Announces Conference ...
04/23/2025 12:05:48

NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (NASDAQ:TARA), a clinical-stage company developing tran...

this-hb-fuller-analyst-turns-bullish-here-are-top-5-upgrades-for-thursday

This H.B. Fuller Analyst Turns Bullish; He...
04/17/2025 11:53:40

this-urogen-pharma-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday

This UroGen Pharma Analyst Begins Coverage...
04/16/2025 13:27:15

Scotiabank Initiates Coverage On Protara T...
04/16/2025 11:47:42

Scotiabank analyst George Farmer initiates coverage on Protara Therapeutics (NASDAQ:TARA) with a Sector Outperform rating an...

Protara Therapeutics To Give 2 Presentatio...
04/10/2025 20:09:11

Protara Therapeutics To Present At America...
03/19/2025 12:07:35

Cantor Fitzgerald Initiates Coverage On Pr...
03/14/2025 14:03:49

Cantor Fitzgerald analyst Li Watsek initiates coverage on Protara Therapeutics (NASDAQ:TARA) with a Overweight rating.

LifeSci Capital Initiates Coverage On Prot...
03/11/2025 12:36:59

LifeSci Capital initiates coverage on Protara Therapeutics (NASDAQ:TARA) with a Outperform rating and announces Price Target ...

HC Wainwright & Co. Reiterates Buy on Prot...
03/06/2025 12:15:53

HC Wainwright & Co. analyst Andrew Fein reiterates Protara Therapeutics (NASDAQ:TARA) with a Buy and maintains $23 price...